Cannabidiol Ameliorates Blood–Brain Barrier Dysfunction and Inhibits Memory Astrocytes Activation in Mice With Sickness‐Like Behaviors
CNS Neuroscience & Therapeutics · 2026-09 · 32 (9)
DOI: 10.1002/cns.71168 ↗Kurz gefasst
Fachartikel in der Zeitschrift CNS Neuroscience & Therapeutics, online erschienen am 16.09.2026. Verfasst von Yue Chen und 12 weiteren Autor:innen. Beteiligte Einrichtung: Academy of Military Medical Sciences, Academy of Military Sciences, Beijing, China. Hauptthemen laut MEDLINE: Astrocytes, Blood-Brain Barrier, Cannabidiol, Depression. Die Arbeit nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Natural Science Foundation of Beijing Municipality, National Natural Science Foundation of China.
Abstract (Originalsprache)
Background
Blood–brain barrier (BBB) dysfunction has been increasingly implicated in the pathophysiology of depression; however, effective therapeutic strategies targeting this pathology remain limited. This study aimed to investigate the effect of cannabidiol (CBD) on improving depressive‐like behaviors and BBB impairment, as well as its underlying mechanism.
Methods
Depressive‐like behaviors in mice were assessed via exploratory and despair‐like tests. BBB integrity was evaluated by examining tight junction protein expression in endothelial cells and AQP4 reduction from the perivascular membrane. Astrocyte activation and neuroinflammation were also measured. The therapeutic effects of a single CBD dose were examined.
Results
Mice with depressive‐like phenotypes showed reduced exploratory behavior and increased despair‐like behavior. In the BBB, the expression of tight junction proteins in endothelial cells was downregulated; in astrocytes, decreased AQP4 expression was observed, abnormal activation was enhanced, and neuroinflammation was elevated. A single dose of CBD alleviated all the above pathological changes. Further studies demonstrated that CBD exerted its effects by inhibiting memory astrocyte–associated secondary neuroinflammation, thereby alleviating depressive‐like behaviors in mice with depressive‐like phenotypes.
Conclusion
Experimental results show that CBD treatment can improve BBB dysfunction in depression and further indicates that targeted inhibition of memory astrocytes‐mediated neuroinflammation may promote the treatment of depression.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Academy of Military Medical Sciences, Academy of Military Sciences, Beijing, China.
- Chinese PLA Medical School, Beijing, China.
ORCID-Profile: Yue Chen, Yan Wang, Xiaoxia Jiang, Xin Qiao
Förderung
- Natural Science Foundation of Beijing Municipality
- National Natural Science Foundation of China
Zitieren
APA
Chen, Y., Ma, H., Long, Q., Fang, X., Li, X., Xiao, W., Deng, X., Du, F., Tan, Y., Wang, Y., Jiang, X., Gao, B., & Qiao, X. (2026). Cannabidiol Ameliorates Blood–Brain Barrier Dysfunction and Inhibits Memory Astrocytes Activation in Mice With Sickness‐Like Behaviors. CNS Neuroscience & Therapeutics, 32(9). https://doi.org/10.1002/cns.71168
Vancouver
Chen Y, Ma H, Long Q, Fang X, Li X, Xiao W, et al. Cannabidiol Ameliorates Blood–Brain Barrier Dysfunction and Inhibits Memory Astrocytes Activation in Mice With Sickness‐Like Behaviors. CNS Neuroscience & Therapeutics. 2026;32(9). doi:10.1002/cns.71168
BibTeX
@article{Chen2026,
author = {Chen, Yue and Ma, Hui and Long, Qian and Fang, Xuan and Li, Xiaotong and Xiao, Wenhui and Deng, Xinzhou and Du, Fuze and Tan, Yifei and Wang, Yan and Jiang, Xiaoxia and Gao, Bo and Qiao, Xin},
title = {Cannabidiol Ameliorates Blood–Brain Barrier Dysfunction and Inhibits Memory Astrocytes Activation in Mice With Sickness‐Like Behaviors},
journal = {CNS Neuroscience & Therapeutics},
year = {2026},
volume = {32},
number = {9},
doi = {10.1002/cns.71168}
}
EUVIMED